This section includes information and resources about Diabetes for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.
Boehringer Ingelheim "Runs" to support vital programs in Diabetes and Stroke
Boehringer Ingelheim and Lilly Revising Operational Structure of Diabetes Alliance in Certain Countries
Type 2 Diabetes: Investigational empagliflozin/linagliptin combination tablet shows sustained reduction in blood glucose in Phase III study
European Commission grants Lilly and Boehringer Ingelheim's insulin glargine product marketing authorisation in Europe
Diabetes: Boehringer Ingelheim and Eli Lilly and Company announce data on portfolio to be presented at the 50th EASD Annual Meeting